Summary.
Capsid-targeted viral inactivation (CTVI) has emerged as a conceptually powerful antiviral strategy that exploits viral structural proteins to target a destructive enzyme specifically into progeny virions. We have recently demonstrated the principle of CTVI against dengue virus infection and observed a modest therapeutic effect in vitro (Arch Virol 2005, 150: 659–669). Here we tested a prophylactic model of CTVI, in which mammalian cells stably expressing the dengue 2 virus capsid protein fused to a nuclease were infected with dengue virus and determined the effects on progeny virion infectivity. CTVI efficiently destroyed dengue 2 virus from within and decreased the infectious titers by 103- to 104-fold, suggesting that CTVI has potential in the prophylactic application for dengue virus infection.
Similar content being viewed by others
References
D Baltimore (1988) ArticleTitleGene therapy. Intracellular immunization. Nature 335 395–396 Occurrence Handle10.1038/335395a0 Occurrence Handle1:STN:280:BieA3svntFM%3D Occurrence Handle3166513
G Beterams B Bottcher M Nassal (2000) ArticleTitlePackaging of up to 240 subunits of a 17 kDa nuclease into the interior of recombinant hepatitis B virus. FEBS Lett 481 169–176 Occurrence Handle10.1016/S0014-5793(00)01927-X Occurrence Handle1:CAS:528:DC%2BD3cXmtlGqsLo%3D Occurrence Handle10996318
G Beterams M Nassal (2001) ArticleTitleSignificant interference with hepatitis B virus replication by a core-nuclease fusion protein. J Biol Chem 276 8875–8883 Occurrence Handle10.1074/jbc.M006335200 Occurrence Handle1:CAS:528:DC%2BD3MXisVCntL4%3D Occurrence Handle11124940
JD Boeke B Hahn (1996) ArticleTitleDestroying retroviruses from within. Trends Microbiol 4 421–426 Occurrence Handle10.1016/0966-842X(96)10065-2 Occurrence Handle1:STN:280:ByiC3cfhs1A%3D Occurrence Handle8950810
BA Bunnell RA Morgan (1998) ArticleTitleGene therapy for infectious diseases. Clin Microbiol Rev 11 42–56 Occurrence Handle1:CAS:528:DyaK1cXntVGmsw%3D%3D Occurrence Handle9457428
MB Crabtree RC Sang V Stollar LM Dunster BR Miller (2003) ArticleTitleGenetic and phenotypic characterization of the newly described insect flavivirus, Kamiti River virus. Arch Virol 148 1095–1118 Occurrence Handle10.1007/s00705-003-0019-7 Occurrence Handle1:CAS:528:DC%2BD3sXjvVCgsLY%3D Occurrence Handle12756617
J Ding J Liu CF Xue WD Gong YH Li Y Zhao (2003) ArticleTitleAnti-HBV effect of TAT-HBV targeted ribonuclease. World J Gastroenterol 9 1525–1528 Occurrence Handle1:CAS:528:DC%2BD3sXoslajtLk%3D Occurrence Handle12854156
MR Hajimorad CC Hu SA Ghabrial (1999) ArticleTitleMolecular characterization of an atypical Old World strain of Peanut stunt virus. Arch Virol 144 1587–1600 Occurrence Handle10.1007/s007050050612 Occurrence Handle1:CAS:528:DyaK1MXmtl2lu70%3D Occurrence Handle10486112
GP Kobinger A Borsetti ZL Nie J Mercier N Daniel HG Gottlinger EA Cohen (1998) ArticleTitleVirion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins. J Virol 72 5441–5448 Occurrence Handle1:CAS:528:DyaK1cXjvFGmu7o%3D Occurrence Handle9620999
P Leyssen E DeClercq J Neyts (2000) ArticleTitlePerspectives for the treatment of infections with Flaviviridae. Clin Microbiol Rev 13 67–82 Occurrence Handle1:CAS:528:DC%2BD3cXntFagtQ%3D%3D Occurrence Handle10627492
GJ Nabel (2004) ArticleTitleGenetic, cellular and immune approaches to disease therapy: past and future. Nat Med 10 135–141 Occurrence Handle10.1038/nm990 Occurrence Handle1:CAS:528:DC%2BD2cXoslKmuw%3D%3D Occurrence Handle14760423
G Natsoulis JD Boeke (1991) ArticleTitleNew antiviral strategy using capsid-nuclease fusion proteins. Nature 352 632–635 Occurrence Handle10.1038/352632a0 Occurrence Handle1:CAS:528:DyaK3MXlsFantb8%3D Occurrence Handle1650915
G Natsoulis P Seshaiah MJ Federspiel A Rein SH Hughes JD Boeke (1995) ArticleTitleTargeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication. Proc Natl Acad Sci USA 92 364–368 Occurrence Handle1:CAS:528:DyaK2MXjt12qsL4%3D Occurrence Handle7831291
N Okui N Kobayashi Y Kitamura (1998) ArticleTitleProduction of uninfectious human immunodeficiency virus type 1 containing viral protein R fused to a single-chain antibody against viral intergrase. J Virol 72 6960–6964 Occurrence Handle1:CAS:528:DyaK1cXks1CjtLc%3D Occurrence Handle9658154
N Okui Y Kitamura N Kobayashi R Sakuma T Ishikawa T Kitamura (2001) ArticleTitleVirion-targeted viral inactivation: new therapy against viral infection. Mol Urol 5 59–66 Occurrence Handle10.1089/109153601300177565 Occurrence Handle1:CAS:528:DC%2BD3MXkt1Cnt7k%3D Occurrence Handle11690549
CF Qin ED Qin (2004) ArticleTitleDevelopment of cell lines stably expressing staphylococcal nuclease fused to dengue 2 virus capsid protein for CTVI. Acta Biochim Biophys Sin 36 577–582 Occurrence Handle1:CAS:528:DC%2BD2cXptlKgtrs%3D Occurrence Handle15295652
CF Qin ED Qin M Yu SP Chen T Jiang YQ Deng HY Duan H Zhao (2004) ArticleTitleTherapeutic effects of dengue 2 virus capsid protein and staphylococcal nuclease fusion protein on dengue-infected cell cultures. Arch Virol 150 659–669 Occurrence Handle15592886
R Rodriguez-Roche M Alvarez T Gritsun D Rosario S Halstead G Kouri EA Gould MG Guzman (2005) ArticleTitleDengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic. Arch Virol 150 415–425 Occurrence Handle10.1007/s00705-004-0445-1 Occurrence Handle1:CAS:528:DC%2BD2MXhvVSqsbw%3D Occurrence Handle15578237
G Schumann L Qin A Rein G Natsoulis JD Boeke (1996) ArticleTitleTherapeutic effect of gag-nuclease fusion protein on retrovirus-infected cell cultures. J Virol 70 4329–4337 Occurrence Handle1:CAS:528:DyaK28XjsFyhu7k%3D Occurrence Handle8676455
G Schumann M Hermankova K Cannon JL Mankowski JD Boeke (2001) ArticleTitleTherapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo. J Virol 75 7030–7041 Occurrence Handle10.1128/JVI.75.15.7030-7041.2001 Occurrence Handle1:CAS:528:DC%2BD3MXlsVCgsrg%3D Occurrence Handle11435583
M VanBrocklin MJ Federspiel (2000) ArticleTitleCapsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro. Virology 267 111–123 Occurrence Handle10.1006/viro.1999.0113 Occurrence Handle1:CAS:528:DC%2BD3cXmsFalsw%3D%3D Occurrence Handle10648188
M VanBrocklin AL Ferris SH Hughes MJ Federspiel (1997) ArticleTitleExpression of a murine leukemia virus Gag-Escherchia coli RNase HI fusion polyprotein significantly inhibits virus spread. J Virol 71 3312–3318 Occurrence Handle1:CAS:528:DyaK2sXhvVGitLc%3D Occurrence Handle9060701
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Qin, CF., Qin, ED. Capsid-targeted viral inactivation can destroy dengue 2 virus from within in vitro. Arch Virol 151, 379–385 (2006). https://doi.org/10.1007/s00705-005-0631-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-005-0631-9